JMM Correspondence
Penicillin/ampicillin efficacy among children with severe pneumonia due to penicillin-resistant pneumococcus (MIC54 mg ml "1 ) Antimicrobials and dosing regimens that have equivalent bacteriological efficacy against susceptible pathogens can have significantly different bacteriological success rates against resistant strains of the same species (Dagan, 2003) . Pneumococcal strains are the most frequent pathogens identified among children with bacterial pneumonia and resistance to penicillin poses a potential problem of choosing the initial antibiotic treatment for these patients (Sinaniotis & Sinaniotis, 2005) . Discordance between in vivo treatment efficacy and in vitro antimicrobial resistance has been reported in pneumococcal infection treated with penicillin (Rothermel, 2004) . The aim of this study was to assess the association between resistance to penicillin in vitro and treatment failure of children with severe pneumococcal pneumonia treated with intravenous penicillin/ampicillin. This was a multicentre, prospective observational study conducted in 12 centres in Argentina, Brazil and the Dominican Republic. Children aged 3-59 months hospitalized with severe pneumonia according to the World Health Organization (WHO) guidelines (WHO, 1990) were included. Any confounding variable such as other concomitant infection, signs of very severe disease (severe malnutrition, stridor in calm child, somnolence, convulsions, nasal flaring, central cyanosis), underlying disease that could interfere with response to pneumonia treatment or known penicillin allergy excluded initially eligible patients. Streptococcus pneumoniae was recovered from blood or pleural fluid. Bacteriological identification was performed according to standard procedures (Facklam & Washington, 1991) (Cardoso et al., 2008) .
The study group included 240 patients, out of which 51 (21 %) presented treatment failure. The final multiple logistic regression analysis included 236 patients because of missing data for the variable 'previous antibiotic use'. The median age of the study group was 15.6 months (mean519.9 months) and 133 (55 %) were males. Table  1 shows the frequency of therapeutic failure by MIC. Table 2 shows the multivariate analysis of treatment failure in patients with pneumococcal strains with different MIC values. Regardless of the small number in the highest MIC group, it is noteworthy that the difference in treatment failure frequency was not significant when children infected with pneumococcal strains with different MICs were compared (P50.31).
There was no strain with MIC .4 mg ml
21
.
In vitro bacteriological efficacy can be predicted by pharmacokinetic/ pharmacodynamic parameters and time that the drug concentration is over the MIC for 40-50 % of the dosing interval is a good predictor of bacteriological efficacy for penicillin (Jacobs, 2003) . The aim of antimicrobial therapy in respiratory tract infections should be bacterial eradication, and penicillin resistance in pneumococcal pneumonia can be overcome by increasing the dose, hence increasing the time during which serum concentrations are above the MIC (Aguado-García et al., 2004). (Heffelfinger et al., 2000) . The DRSP suggested the aforementioned classification in order to parallel penicillin resistance categories with clinical outcomes (Heffelfinger et al., 2000) . Our results corroborate the upward shift of penicillin susceptibility categories that was recommended as of the year 2008 (CLSI, 2008 
